Amarin Corporation plc AMRN
i
Market dataready · fetched 2026-11-12T15:08:34.644Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T14:59:26.352895284Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T15:08:34.106922+00:00
Amarin Corporation plc options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 9.05 | 205.7% | 23.9% | |||
| 25Δ | 23.76 | 469.6% | 116.1% | 10.11 | 136.9% | 14.6% |
| 30Δ | 10.49 | 117.9% | 11.5% | |||
| 35Δ | 12.36 | 110.1% | 11.9% | 10.86 | 98.9% | 8.4% |
| 40Δ | 12.03 | 106.5% | 9.6% | 11.10 | 89.0% | 6.7% |
| 45Δ | 11.76 | 109.5% | 8.6% | 11.25 | 84.1% | 5.8% |
| 50Δ | 11.49 | 113.1% | 7.7% | 11.40 | 79.3% | 5.0% |
| 55Δ | 11.22 | 116.7% | 6.9% | 11.55 | 74.5% | 4.1% |
| 60Δ | 10.95 | 120.3% | 6.0% | 11.70 | 69.7% | 3.2% |
| 65Δ | 10.69 | 124.0% | 5.1% | 11.85 | 64.9% | 2.4% |
| 70Δ | 10.42 | 127.6% | 4.2% | |||
| 75Δ | 10.15 | 131.2% | 3.4% | |||
| 80Δ | 9.67 | 149.3% | 2.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.05
- IV
- 205.7%
- B/E move
- 23.9%
25Δ
- Pseudo strike
- 23.76
- IV
- 469.6%
- B/E move
- 116.1%
- Pseudo strike
- 10.11
- IV
- 136.9%
- B/E move
- 14.6%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.49
- IV
- 117.9%
- B/E move
- 11.5%
35Δ
- Pseudo strike
- 12.36
- IV
- 110.1%
- B/E move
- 11.9%
- Pseudo strike
- 10.86
- IV
- 98.9%
- B/E move
- 8.4%
40Δ
- Pseudo strike
- 12.03
- IV
- 106.5%
- B/E move
- 9.6%
- Pseudo strike
- 11.10
- IV
- 89.0%
- B/E move
- 6.7%
45Δ
- Pseudo strike
- 11.76
- IV
- 109.5%
- B/E move
- 8.6%
- Pseudo strike
- 11.25
- IV
- 84.1%
- B/E move
- 5.8%
50Δ
- Pseudo strike
- 11.49
- IV
- 113.1%
- B/E move
- 7.7%
- Pseudo strike
- 11.40
- IV
- 79.3%
- B/E move
- 5.0%
55Δ
- Pseudo strike
- 11.22
- IV
- 116.7%
- B/E move
- 6.9%
- Pseudo strike
- 11.55
- IV
- 74.5%
- B/E move
- 4.1%
60Δ
- Pseudo strike
- 10.95
- IV
- 120.3%
- B/E move
- 6.0%
- Pseudo strike
- 11.70
- IV
- 69.7%
- B/E move
- 3.2%
65Δ
- Pseudo strike
- 10.69
- IV
- 124.0%
- B/E move
- 5.1%
- Pseudo strike
- 11.85
- IV
- 64.9%
- B/E move
- 2.4%
70Δ
- Pseudo strike
- 10.42
- IV
- 127.6%
- B/E move
- 4.2%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 10.15
- IV
- 131.2%
- B/E move
- 3.4%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 9.67
- IV
- 149.3%
- B/E move
- 2.8%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 73.66% | |
| 80.28% | |
| 97.14% | |
| 70.68% | |
| 69.87% | |
| 69.78% | |
| 66.46% | |
| 70.45% | |
| 63.09% | |
| 67.65% | |
| 62.25% | |
| 67.09% | |
| 66.93% | |
| 67.93% | |
| 75.91% | |
| 73.98% | |
| 87.74% | |
| 68.86% | |
| 77.28% | |
| 79.71% | |
| 93.33% | |
| 96.69% | |
| 67.93% | |
| 67.45% | |
| 63.85% | |
| 63.03% | |
| 69.04% | |
| 71.82% | |
| 72.60% | |
| 70.01% | |
| 70.04% | |
| 73.19% | |
| 71.66% | |
| 79.70% | |
| 81.99% | |
| 79.51% | |
| 77.58% | |
| 85.46% | |
| 100.56% | |
| 113.61% | |
| 113.77% | |
| 117.43% | |
| 76.58% | |
| 73.46% | |
| 72.11% | |
| 71.48% | |
| 71.48% | |
| 76.22% | |
| 76.27% | |
| 74.85% | |
| 79.10% | |
| 63.96% | |
| 67.78% |
Drug Manufacturers - General
AZN
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections,…
More →BIIB
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the…
More →BMY
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and…
More →GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the…
More →GRFS
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
More →GSK
Description unavailable
More →